Cargando…
Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
Clinical implementation of hypofractionated prostate radiotherapy (PROFIT trial, NCT003046759) represents an opportunity to significantly reduce the burden of treatment on the patient and clinic. However, efficacy was only demonstrated among the patient demographic who could meet the trial dose cons...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689926/ https://www.ncbi.nlm.nih.gov/pubmed/28980442 http://dx.doi.org/10.1002/acm2.12198 |